IκB kinase complex and upstream NF-κB–activating kinases (IKK complex)

The IκB kinase (IKK) complex and its upstream activating kinases constitute the central signal integration hub for the NF-κB signaling pathway, which is a master regulator of immune and inflammatory responses (1.1.1). The core IKK complex typically consists of two catalytic subunits, IKKα (IKK1) and IKKβ (IKK2), and a regulatory subunit, IKKγ (NEMO) (1.1.3). Activation of this complex is mediated by various upstream kinases, such as TAK1 (Transforming growth factor-beta-activated kinase 1) in the canonical pathway and NIK (NF-κB-inducing kinase) in the non-canonical pathway, which respond to stimuli like pro-inflammatory cytokines (TNF-α, IL-1) and pathogen-associated molecular patterns (1.2.1, 1.3.1). Once activated, the IKK complex phosphorylates IκB proteins, leading to their proteasomal degradation and the subsequent nuclear translocation of NF-κB transcription factors (1.1.2). Dysregulation of this pathway is a hallmark of many chronic inflammatory diseases and cancers, where it promotes cell survival, proliferation, and resistance to therapy (1.2.2, 1.3.3). Consequently, the IKK complex and its upstream activators are high-priority therapeutic targets, although the development of clinical inhibitors has been hampered by significant safety concerns, including severe immunosuppression and systemic toxicity (1.2.2).

Other names

IκB kinase complexIKK complexIKK1/IKK2/NEMO complexNF-κB-inducing kinase (NIK)Transforming growth factor-beta-activated kinase 1 (TAK1)MAP3K7MAP3K14CHUK/IKBKB/IKBKG complexIKKα/IKKβ/IKKγ complex

Inhibition of the catalytic activity of IKKα, IKKβ, or upstream kinases such as NIK and TAK1 to prevent the phosphorylation of IκB proteins, thereby blocking the nuclear translocation and transcriptional activity of NF-κB (1.1.1, 1.2.2).